Supplying COVID-19 pills at lower cost is only part of what poorer countries need

By Kelly Chibale, Professor of Organic Chemistry, Neville Isdell Chair in African-centric Drug Discovery & Development, and Director of the Holistic Drug Discovery and Development (H3D) Centre, University of Cape Town

November 2021 marks another grim flashpoint in a stream of them: the global COVID-19 death toll surpassed five million. The rapid development of vaccines has been an extraordinary achievement in the fight against COVID-19. However, successfully vaccinating the global population, especially in low-income countries, has been hampered by several challenges – notably vaccine inequity and weak health systems.

For instance, just 6% of Africa’s population has…

Read complete article

~	Why I must write about Amarah Lalitte, a little girl brutally murdered in Trinidad

~	AfrikElles: Togolese media outlet putting African women at the center of its editorial line

~	A decade after the kidnapping of the Chibok girls in Nigeria, what has the #BringBackOurGirls movement achieved?

~	What’s next for Turkey after local elections put Erdoğan on notice

~	How a little-known clergyman studying worms by candlelight in the 1700s inspired Charles Darwin – but didn’t get the credit he deserved

~	Hoarding can start in childhood – here’s why early intervention is so crucial for all age groups

~	AI has the power to revolutionise lending, but at a cost to people with lower credit scores

~	Mounting tension and instability in the western Balkans is playing into Russia’s hands

~	Robert F. Kennedy Jr. reveals why he has a raspy voice – spasmodic dysphonia explained

~	Japan: the yen plunges to 34-year low despite interest rate hike